|1.||Garcia, Joe G N: 10 articles (01/2015 - 02/2005)|
|2.||Nencioni, Alessio: 9 articles (09/2015 - 01/2009)|
|3.||Miao, Chao-Yu: 9 articles (07/2015 - 09/2010)|
|4.||Wang, Pei: 9 articles (07/2015 - 09/2010)|
|5.||D'Angelo, Angela: 8 articles (05/2015 - 01/2010)|
|6.||Maffioli, Pamela: 8 articles (05/2015 - 01/2010)|
|7.||Derosa, Giuseppe: 8 articles (05/2015 - 01/2010)|
|8.||Olszanecka-Glinianowicz, Magdalena: 8 articles (04/2015 - 08/2007)|
|9.||Chudek, Jerzy: 8 articles (04/2015 - 05/2012)|
|10.||Boutsikou, Maria: 8 articles (09/2014 - 01/2007)|
02/01/2015 - "The purpose of the present study is to determine if visfatin is involved in inflammation or apoptosis induced by LPS in rat. "
01/01/2015 - "According to the findings of this study it seems that there is a direct relationship between periodontal tissue inflammation and disease activity with salivary and serum visfatin levels. "
01/01/2013 - "The aim of the study was to investigate the association of visfatin with well-known markers of inflammation and endothelial dysfunction. "
12/01/2010 - "This study aimed to assess visfatin in correlation with markers of ED and inflammation in Egyptian patients with CKD. "
03/01/2010 - "The aim of the study was to assess visfatin in correlation with markers of endothelial damage and inflammation in haemodialyzed and peritoneally dialyzed patients. "
11/01/2014 - "Therefore, the aim of our study was to assess the relationships between circulating visfatin/NAMPT levels, nutritional status, and insulin resistance in a large population of the elderly. "
07/01/2013 - "A significant correlation between visfatin concentrations and insulin resistance (HOMA at the time of the study) was found (r= 0.493; p=0.009). "
01/01/2013 - "The objectives of this study were to measure visfatin/Nampt, vaspin, and RBP-4 concentrations in blood, liver, muscle, subcutaneous, omental, and mesenteric adipose tissues in morbidly obese subjects and investigate their relationship to insulin resistance. "
05/01/2012 - "The aim of the present study was to compare serum visfatin levels between patients with GDM and subjects with normal pregnancy and to evaluate its relationship with dietary intake and components of insulin-resistance syndrome. "
07/23/2011 - "The aim of the present study was to explore the relation of visfatin with insulin resistance, cardiovascular risk factors and anthropometry in obese patients without comorbidities. "
01/01/2014 - "This study aimed to evaluate the prognostic value of preoperative serum visfatin level in breast cancers. "
04/01/2011 - "Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents."
08/01/2015 - "Viability and oxidative response of human colorectal HCT-116 cancer cells treated with visfatin/eNampt in vitro."
08/01/2015 - "Visfatin is considered to be a biomarker in various types of cancers. "
07/01/2015 - "Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer."
|4.||Type 2 Diabetes Mellitus (MODY)
10/01/2015 - "There is evidence based studies which show that plasma level of visfatin and vaspin in patients with type 2 diabetes mellitus elevate in comparison with healthy people. "
01/01/2008 - "Since evidence of a direct link between visfatin genotype and human type 2 diabetes mellitus is still weak, more molecular, physiological and clinical studies are needed to determine the role of visfatin in the etiology and pathogenesis of type 2 diabetes mellitus."
04/01/2007 - "The main purpose of this study was to investigate the association of plasma visfatin with endothelial function in patients with type 2 diabetes mellitus. "
09/01/2006 - "In this study, we explored the relationships between the plasma level of visfatin and genetic single nucleotide polymorphisms (SNPs) and Type 2 diabetes mellitus (T2DM) and anthropometric and metabolic parameters in Chinese subjects. "
01/01/2006 - "In this study we investigated whether plasma visfatin level is altered in patients with type 2 diabetes mellitus (T2DM). "
|5.||Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
10/01/2015 - "Previous studies regarding visfatin levels in women with polycystic ovary syndrome (PCOS) showed conflicting results. "
08/01/2012 - "The aim of this study is to determine the serum levels of visfatin in patients with polycystic ovary syndrome (PCOS) and to understand its correlations with other metabolic and hormonal parameters. "
10/01/2011 - "The aims of the study were to compare the expression of visfatin in PBMCs with that in omental adipose tissue in women with polycystic ovary syndrome (PCOS). "
07/01/2011 - "The aim of this study is to compare the serum level of visfatin between patients with polycystic ovary syndrome (PCOS) and control subjects matched for age and body mass index (BMI) and to assess the possible correlations of visfatin to the hormonal and metabolic parameters of the syndrome. "
10/01/2008 - "The present study was designed to measure plasma visfatin levels in normal weight women with polycystic ovary syndrome (PCOS) and to assess possible correlations between visfatin and the hormonal or metabolic parameters of the syndrome. "
|7.||Carrier Proteins (Binding Protein)
|10.||Dual Specificity Phosphatase 1
|1.||Gastric Bypass (Roux-en-Y Gastric Bypass)
|3.||Renal Dialysis (Hemodialysis)
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)